Aller au menu Aller au contenu
Synthèse et propriétés de monocristaux, de poudres, films minces ou hétérostructures

Etudes à l'interface avec la matière biologique

> LMGP_Présentation > LMGP_Actualites

Séminaire LMGP - 31/05/2018 - Sylvie Noinville

Publié le 28 mai 2018
A+Augmenter la taille du texteA-Réduire la taille du texteImprimer le documentEnvoyer cette page par mail cet article Facebook Twitter Linked In
Colloque / Séminaire 29 mai 2018
Grenoble INP - Phelma
3 parvis Louis Néel - 38000 Grenoble
Accès : TRAM B arrêt Cité internationale
Free entrance - No registration
14h salle de séminaire du LMGP

Prion proteins at interfaces : links with pathological activity

Dr , Sylvie Noinville 
CNRS-Sorbonne Universités (UPMC), Laboratoire MONARIS, Paris 75005

Prion diseases belong to the growing group of disorders that are attributed to misfolding and ordered aggregation of proteins, which include Alzheimer’s disease, Parkinson’s disease and many others [1]. The a-to-b conversion of normal PrPC to its pathological isoform PrPSc is a key event in transmissible encephalopathies. The specificity of the PrP is to adopt a wide range of conformations following chemical and physical perturbations. Surface-induced conformational changes of PrP are at the origin of accelerating fibrillation or to prevent it depending on the chemical nature of solid synthetic models or lipid bilayers, as shown by FTIR-ATR [2]. A convergence of evidence strongly suggests that soluble oligomers or small fibrillar fragments of PrP, as on- or off-pathway products, are considered to be the most toxic species in prion diseases. Soluble discrete oligomers were obtained depending on the single mutation or truncation of the full length primary sequence, and then purified. We compare their structural properties when associated with anionic lipid bilayers and study their propensities to permeabilize the membrane. The impairments of the membrane by the soluble oligomers are correlated to their neuronal toxicities at submicromolar concentrations as shown by cell culture assays [3].  

1 .Collinge J, Prion diseases of humans and animals: their causes and molecular basis, Annu. Rev. Neurosci, 2001, 24, 519-550

2. Chich, J. F.; Chapuis, C.; Henry, C.; Vidic, J.; Rezaei, H.; Noinville, S., Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes. J Mol Biol 2010, 397, (4), 1017-30.

3. Crosnier, S.; Beringue, V.; Rezaei, H.; Noinville, S., Membrane permeabilization and neuronal toxicities induced by PrP oligomers: essential role of the H2H3 oligomerization domain for neurotoxicity J.Biol.Chem submitted.

A+Augmenter la taille du texteA-Réduire la taille du texteImprimer le documentEnvoyer cette page par mail cet article Facebook Twitter Linked In

mise à jour le 28 mai 2018

  • Tutelle CNRS
  • Tutelle UGA
  • Tutelle Grenoble INP
Université Grenoble Alpes